Global and Region Nano-drug Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Nano-drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Nano-drugmarket, defines the market attractiveness level of Nano-drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Nano-drug industry, describes the types of Nano-drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nano-drug market and the development prospects and opportunities of Nano-drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nano-drug market in Chapter 13.

    By Player:

    • Cerulean Pharma

    • Pfizer

    • Mitsubishi Pharma

    • GlaxoSmithKline

    • Stryker

    • Celgene

    • Johnson & Johnson

    • Par Pharmaceutical

    • Merck

    • Lummy

    • Gilead Sciences

    • Roche

    • Selecta Biosciences

    • Abbott

    • Astrazeneca

    • Kaken Pharmaceutical

    • OSI Pharmaceuticals

    • Navidea Biopharmaceuticals

    • Eli Lilly

    • Sanofi

    • Samyang Biopharm

    • Kadmon Pharmaceuticals

    • Novavax

    • Novartis

    By Type:

    • Liposomes

    • Polymeric Micelles

    • Solid lipid Nanoparticles

    • Microemulsion and Nanoemulsion

    • Nanosuspension

    By End-User:

    • Cancer and Tumors

    • Autoimmune Disorders

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Nano-drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Nano-drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Nano-drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Nano-drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Nano-drug Market Analysis and Outlook to 2022

    • 7.1 Global Nano-drug Consumption (2017-2022)

    • 7.2 United States Nano-drug Consumption (2017-2022)

    • 7.3 Europe Nano-drug Consumption (2017-2022)

    • 7.4 China Nano-drug Consumption (2017-2022)

    • 7.5 Japan Nano-drug Consumption (2017-2022)

    • 7.6 India Nano-drug Consumption (2017-2022)

    • 7.7 South Korea Nano-drug Consumption (2017-2022)

    8 Region and Country-wise Nano-drug Market Analysis and Outlook to 2028

    • 8.1 Global Nano-drug Consumption Forecast (2022-2028)

    • 8.2 United States Nano-drug Consumption Forecast (2022-2028)

    • 8.3 Europe Nano-drug Consumption Forecast (2022-2028)

    • 8.4 China Nano-drug Consumption Forecast (2022-2028)

    • 8.5 Japan Nano-drug Consumption Forecast (2022-2028)

    • 8.6 India Nano-drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Nano-drug Consumption Forecast (2022-2028)

    9 Global Nano-drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Nano-drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Liposomes Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Polymeric Micelles Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Solid lipid Nanoparticles Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Microemulsion and Nanoemulsion Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Nanosuspension Consumption and Growth Rate (2017-2022)

    • 9.2 Global Nano-drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Cancer and Tumors Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Autoimmune Disorders Consumption and Growth Rate (2017-2022)

    10 Global Nano-drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Nano-drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Liposomes Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Polymeric Micelles Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Solid lipid Nanoparticles Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Microemulsion and Nanoemulsion Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Nanosuspension Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Nano-drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Cancer and Tumors Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Autoimmune Disorders Consumption Forecast and Growth Rate (2022-2028)

    11 Global Nano-drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Nano-drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Nano-drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Nano-drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Nano-drug Market Competitive Analysis

    • 14.1 Cerulean Pharma

      • 14.1.1 Cerulean Pharma Company Details

      • 14.1.2 Cerulean Pharma Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Cerulean Pharma Nano-drug Product and Service

    • 14.2 Pfizer

      • 14.2.1 Pfizer Company Details

      • 14.2.2 Pfizer Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pfizer Nano-drug Product and Service

    • 14.3 Mitsubishi Pharma

      • 14.3.1 Mitsubishi Pharma Company Details

      • 14.3.2 Mitsubishi Pharma Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Mitsubishi Pharma Nano-drug Product and Service

    • 14.4 GlaxoSmithKline

      • 14.4.1 GlaxoSmithKline Company Details

      • 14.4.2 GlaxoSmithKline Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 GlaxoSmithKline Nano-drug Product and Service

    • 14.5 Stryker

      • 14.5.1 Stryker Company Details

      • 14.5.2 Stryker Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Stryker Nano-drug Product and Service

    • 14.6 Celgene

      • 14.6.1 Celgene Company Details

      • 14.6.2 Celgene Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Celgene Nano-drug Product and Service

    • 14.7 Johnson & Johnson

      • 14.7.1 Johnson & Johnson Company Details

      • 14.7.2 Johnson & Johnson Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Johnson & Johnson Nano-drug Product and Service

    • 14.8 Par Pharmaceutical

      • 14.8.1 Par Pharmaceutical Company Details

      • 14.8.2 Par Pharmaceutical Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Par Pharmaceutical Nano-drug Product and Service

    • 14.9 Merck

      • 14.9.1 Merck Company Details

      • 14.9.2 Merck Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Merck Nano-drug Product and Service

    • 14.10 Lummy

      • 14.10.1 Lummy Company Details

      • 14.10.2 Lummy Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Lummy Nano-drug Product and Service

    • 14.11 Gilead Sciences

      • 14.11.1 Gilead Sciences Company Details

      • 14.11.2 Gilead Sciences Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Gilead Sciences Nano-drug Product and Service

    • 14.12 Roche

      • 14.12.1 Roche Company Details

      • 14.12.2 Roche Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Roche Nano-drug Product and Service

    • 14.13 Selecta Biosciences

      • 14.13.1 Selecta Biosciences Company Details

      • 14.13.2 Selecta Biosciences Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Selecta Biosciences Nano-drug Product and Service

    • 14.14 Abbott

      • 14.14.1 Abbott Company Details

      • 14.14.2 Abbott Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Abbott Nano-drug Product and Service

    • 14.15 Astrazeneca

      • 14.15.1 Astrazeneca Company Details

      • 14.15.2 Astrazeneca Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Astrazeneca Nano-drug Product and Service

    • 14.16 Kaken Pharmaceutical

      • 14.16.1 Kaken Pharmaceutical Company Details

      • 14.16.2 Kaken Pharmaceutical Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Kaken Pharmaceutical Nano-drug Product and Service

    • 14.17 OSI Pharmaceuticals

      • 14.17.1 OSI Pharmaceuticals Company Details

      • 14.17.2 OSI Pharmaceuticals Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 OSI Pharmaceuticals Nano-drug Product and Service

    • 14.18 Navidea Biopharmaceuticals

      • 14.18.1 Navidea Biopharmaceuticals Company Details

      • 14.18.2 Navidea Biopharmaceuticals Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Navidea Biopharmaceuticals Nano-drug Product and Service

    • 14.19 Eli Lilly

      • 14.19.1 Eli Lilly Company Details

      • 14.19.2 Eli Lilly Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Eli Lilly Nano-drug Product and Service

    • 14.20 Sanofi

      • 14.20.1 Sanofi Company Details

      • 14.20.2 Sanofi Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Sanofi Nano-drug Product and Service

    • 14.21 Samyang Biopharm

      • 14.21.1 Samyang Biopharm Company Details

      • 14.21.2 Samyang Biopharm Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Samyang Biopharm Nano-drug Product and Service

    • 14.22 Kadmon Pharmaceuticals

      • 14.22.1 Kadmon Pharmaceuticals Company Details

      • 14.22.2 Kadmon Pharmaceuticals Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 Kadmon Pharmaceuticals Nano-drug Product and Service

    • 14.23 Novavax

      • 14.23.1 Novavax Company Details

      • 14.23.2 Novavax Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.23.3 Novavax Nano-drug Product and Service

    • 14.24 Novartis

      • 14.24.1 Novartis Company Details

      • 14.24.2 Novartis Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.24.3 Novartis Nano-drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Nano-drug

    • Figure Nano-drug Picture

    • Table Global Nano-drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nano-drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nano-drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Nano-drug Consumption by Country (2017-2022)

    • Figure United States Nano-drug Consumption and Growth Rate (2017-2022)

    • Table Europe Nano-drug Consumption and Growth Rate (2017-2022)

    • Figure China Nano-drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Nano-drug Consumption and Growth Rate (2017-2022)

    • Figure India Nano-drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Nano-drug Consumption and Growth Rate (2017-2022)

    • Figure Global Nano-drug Consumption Forecast by Country (2022-2028)

    • Figure United States Nano-drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Nano-drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Nano-drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Nano-drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Nano-drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Nano-drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liposomes Consumption and Growth Rate (2017-2022)

    • Figure Global Polymeric Micelles Consumption and Growth Rate (2017-2022)

    • Figure Global Solid lipid Nanoparticles Consumption and Growth Rate (2017-2022)

    • Figure Global Microemulsion and Nanoemulsion Consumption and Growth Rate (2017-2022)

    • Figure Global Nanosuspension Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer and Tumors Consumption and Growth Rate (2017-2022)

    • Figure Global Autoimmune Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Liposomes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Polymeric Micelles Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Solid lipid Nanoparticles Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Microemulsion and Nanoemulsion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nanosuspension Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer and Tumors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autoimmune Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Nano-drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Nano-drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Cerulean Pharma (Foundation Year, Company Profile and etc.)

    • Table Cerulean Pharma Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cerulean Pharma Nano-drug Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Nano-drug Product and Service

    • Table Mitsubishi Pharma (Foundation Year, Company Profile and etc.)

    • Table Mitsubishi Pharma Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mitsubishi Pharma Nano-drug Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Nano-drug Product and Service

    • Table Stryker (Foundation Year, Company Profile and etc.)

    • Table Stryker Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stryker Nano-drug Product and Service

    • Table Celgene (Foundation Year, Company Profile and etc.)

    • Table Celgene Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Nano-drug Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Nano-drug Product and Service

    • Table Par Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Par Pharmaceutical Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Par Pharmaceutical Nano-drug Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Nano-drug Product and Service

    • Table Lummy (Foundation Year, Company Profile and etc.)

    • Table Lummy Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lummy Nano-drug Product and Service

    • Table Gilead Sciences (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Nano-drug Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Nano-drug Product and Service

    • Table Selecta Biosciences (Foundation Year, Company Profile and etc.)

    • Table Selecta Biosciences Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Selecta Biosciences Nano-drug Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Nano-drug Product and Service

    • Table Astrazeneca (Foundation Year, Company Profile and etc.)

    • Table Astrazeneca Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astrazeneca Nano-drug Product and Service

    • Table Kaken Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Kaken Pharmaceutical Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kaken Pharmaceutical Nano-drug Product and Service

    • Table OSI Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table OSI Pharmaceuticals Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table OSI Pharmaceuticals Nano-drug Product and Service

    • Table Navidea Biopharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Navidea Biopharmaceuticals Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Navidea Biopharmaceuticals Nano-drug Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Nano-drug Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Nano-drug Product and Service

    • Table Samyang Biopharm (Foundation Year, Company Profile and etc.)

    • Table Samyang Biopharm Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Samyang Biopharm Nano-drug Product and Service

    • Table Kadmon Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Kadmon Pharmaceuticals Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kadmon Pharmaceuticals Nano-drug Product and Service

    • Table Novavax (Foundation Year, Company Profile and etc.)

    • Table Novavax Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novavax Nano-drug Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Nano-drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Nano-drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.